Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation
Remarks:
other: in chemico
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: In-house validated in vitro study, reported as summary, non-GLP

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2014
Report date:
2014

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: Direct peptide binding assay (DPRA) performed as described in Bauch C. et al. (2011), Toxicology in Vitro 25, 1162 – 1168.
Principles of method if other than guideline:
Binding to Cysteine and Lysine containing model peptides in chemico
GLP compliance:
no
Type of study:
other: Direct peptide binding assay

Test material

Constituent 1
Reference substance name:
Automatically generated during migration to IUCLID 6, no data available
IUPAC Name:
Automatically generated during migration to IUCLID 6, no data available
Details on test material:
- Name of test material (as cited in study report): 2-(2-Methylallyl)-cyclododecanon-Rein
- Physical state: Liquid/ colorless, clear
- Analytical purity: 99.3 area-% (not corrected with the water content), Capillary GC-analysis
- Lot/batch No.: 2-(2-Meth-allyl)cyclododecanon (MACD Probe aus B410.16 vom 04.10.2012)
- Storage condition of test material: Room temperature

In vivo test system

Test animals

Species:
other: not applicable
Strain:
other: not applicable
Details on test animals and environmental conditions:
not applicable

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
other: not applicable
Vehicle:
other: not applicable
Concentration / amount:
Test substance was solved at a 100 mM concentration in acetonitrile.
Test substance were incubated with each peptide in ratios of 1:10 (for C-peptide) or 1:50 (for K-peptide).
Challengeopen allclose all
Route:
other: not applicable
Vehicle:
other: not applicable
Concentration / amount:
Test substance was solved at a 100 mM concentration in acetonitrile.
Test substance were incubated with each peptide in ratios of 1:10 (for C-peptide) or 1:50 (for K-peptide).
No. of animals per dose:
not applicable
Details on study design:
not applicable
Challenge controls:
not applicable
Positive control substance(s):
yes
Remarks:
EGDMA

Results and discussion

Positive control results:
The mean Cysteine-peptide depletion, caused by the PC was determined to be 50.7 %.
The mean Lysine-peptide depletion, caused by the PC was determined to be 13.94%.

Any other information on results incl. tables

The mean Cysteine-peptide depletion, caused by the test substance was determined to be 5.61%.

The mean Lysine-peptide depletion, caused by the test substance was determined to be -3.21 %.

No co-elution of test substance and peptides was noticed.

The samples of the test substance with the peptides were emulsions directly after application and after the 24-hour incubation time. Thus

the samples were centrifuged prior to HPLC analysis.

Applicant's summary and conclusion

Interpretation of results:
other: Non peptide binding
Conclusions:
In a weight of evidence, all present in vitro data on dermal sensitization do not fulfill the criteria laid down in 67/548/EEC and regulation (EU) 1272/2008, and therefore, a non-classification is warranted.